Jade Biosciences, Inc. Common Stock

JBIO XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

880M

Short interest (May 15)

6.9%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.61%

↑ 0.6%

Available Shares

700K

↑ 10.3%

Price Chart

Company Overview

Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001798749

Asset Type: CS

Market Data

Market Cap: $876,137,781

Employees: 55

Status: Active

Short Interest

Current Borrow Fee 0.61%

Range: 0.59% - 0.67%

Available Shares 700K

Range: 450K - 700K

Recent Changes

Fee Change: ↓ 0.6%

Available Change: ↑ 36.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime